FDA Approves METFORMIN HYDROCHLORIDE — Amneal Pharmaceuticals LLC
Amneal Pharmaceuticals LLC has received FDA approval for Metformin Hydrochloride under ANDA078596. Approval of this oral antidiabetic could bolster generics availability as market dynamics shift.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day